Global Non-opioid Pain Patches Market Size study, by Product Type (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stor

Global Non-opioid Pain Patches Market Size study, by Product Type (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, Others) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies) and Regional Forecasts 2022-2028

Global Non-opioid Pain Patches Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Non-opioid pain patches use Active Pharmaceutical Ingredients (APIs) for delivering therapeutic effects. Patches works by blocking body’s sensation of pain signals through receptors. Pain Patches relieves muscle spasms and reduce . Growing prevalence of osteoarthritis and rising incidence of Acute and Chronic Pain Conditions are key drivers for the growth of Non-opioid Pain Patches market. For instance, according to Centers for Disease Control and Prevention- By the year 2040, an estimated 78.4 million adults aged 18 years and older will have doctor-diagnosed arthritis, compared with the 58.5 million adults during 2013–2015. Furthermore, as per Arthritis Foundation’s OSTEOARTHRITIS: 2020 UPDATE report – As of 2020, Osteoarthritis (OA), affects 1 in 7 US adults, accounting for around 32.5 million people. Also, with the increasing geriatric population and rising preference of Online Pharmacies, the adoption & demand for Non-opioid Pain Patches is likely to increase the market growth during the forecast period. However, high cost of Non-opioid Pain Patches and disruption in supply chain due to pandemic impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Non-opioid Pain Patches Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share owing to increasing geriatric population and presence of leading market players in the region. Whereas Asia-Pacific is anticipated to exhibit highest growth rate over the forecast period 2022-2028. Factors such as growing healthcare infrastructure and rising incidence of Chronic Pain-related Conditions would create lucrative growth prospects for the Non-opioid Pain Patches market across Asia-Pacific region.

Major market player included in this report are:
Sanofi S.A. Ltd.
Pfizer Inc.
GlaxoSmithKline Plc.
Hisamitsu Pharmaceutical Co., Inc.
Clarion Brands, LLC
Endo International plc
TEH SENG Pharmaceutical Mfg. Co., Ltd.
Veridian Healthcare, LLC.
Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Capsaicin Patches
Ketoprofen Patches
Others
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Non-opioid Pain Patches Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Sanofi S.A. Ltd.
Pfizer Inc.
GlaxoSmithKline Plc.
Hisamitsu Pharmaceutical Co., Inc.
Clarion Brands, LLC
Endo International plc
TEH SENG Pharmaceutical Mfg. Co., Ltd.
Veridian Healthcare, LLC.
Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.